You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Korea

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quadrivalent Influenza Vaccine in Subjects Aged 6 to 35 Months

Completed
  • Influenza
  • VaxigripTetra®
  • Gangwon-do, Korea, Republic of
  • +11 more
Apr 26, 2023

Acute Myocarditis in Korea

Completed
  • Myocarditis Acute
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jul 3, 2023

    Meningitis, Meningococcal Trial in Korea, Republic of (rMenB+OMV NZ)

    Not yet recruiting
    • Meningitis, Meningococcal
    • rMenB+OMV NZ
    • Anyang-Si, Gyeonggi-do, Korea, Republic of
    • +6 more
    Oct 27, 2023

    Functional Dyspepsia Trial in Seoul (Mastic gum, Dietary modification)

    Recruiting
    • Functional Dyspepsia
    • Mastic gum
    • Dietary modification
    • Seoul, Korea, Republic of
      Seoul National University Hospital Clinical Trial Center
    Aug 22, 2023

    'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

    Recruiting
    • Ovarian Cancer
    • +3 more
      • Busan, Korea, Republic of
      • +17 more
      Jan 9, 2023

      Dapagliflozin Post Marketing Surveillance in HF and CKD

      Recruiting
      • Heart Failure With Reduced Ejection Fraction
      • Chronic Kidney Disease
        • Busan, Korea, Republic of
        • +28 more
        Jan 9, 2023

        An Observational Study of Kadcyla Safety in Breast Cancer

        Completed
        • Breast Cancer
          • Busan, Korea, Republic of
          • +37 more
          Jan 10, 2023

          Non Squamous Non Small Cell Lung Cancer Trial in Korea, Republic of (Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin)

          Not yet recruiting
          • Non Squamous Non Small Cell Lung Cancer
          • Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin
          • Anam, Korea, Republic of
          • +7 more
          May 1, 2023

          Adults in South Korea With Cancer Who Receive PADCEV Injection

          Recruiting
          • Urothelial Cancer
          • Enfortumab Vedotin
          • Seoul, Korea, Republic of
            KR82004
          Aug 22, 2023

          A Post Marketing Surveillance on Piqray in Korea

          Recruiting
          • Breast Cancer
          • Piqray
          • Deogyang Gu Goyang Si, Gyeonggi Do, Korea, Republic of
          • +4 more
          Jan 16, 2023

          Textbook and Survival Outcomes of MIPD in South Korea

          Completed
          • Surgery-Complications
            • Seoul, Korea, Republic of
              Asan medical center
            Aug 2, 2023

            Alectinib in Anaplastic Lymphoma Kinase-Positive, Locally

            Completed
            • Non-Small Cell Lung Cancer
            • Busan, Korea, Republic of
            • +36 more
            Nov 17, 2022

            Lazertinib Trial in Suwon-si, Goyang-si, Seoul (Lazertinib, Bevacizumab Injectable Product)

            Recruiting
            • Lazertinib
            • Suwon-si, Gyeonggi-do,, Korea, Republic of
            • +4 more
            Nov 27, 2023

            Assess Safety of Ozanimod in Moderate to Severe Active UC in

            Not yet recruiting
            • Ulcerative Colitis
            • Seoul, Korea, Republic of
              Bristol-Myers Squibb YH
            Oct 3, 2023

            Cervical Cancer, Endometrial Cancer, Ovarian Cancer Trial in Seoul (Patient registry)

            Recruiting
            • Cervical Cancer
            • +4 more
            • Patient registry
            • Seoul, Korea, Republic of
              Department of Obstetrics and Gynecology, University of Ulsan Col
            Jun 12, 2023

            Evaluation of POMALYST® Treatment of Multiple Myeloma in Korea

            Recruiting
            • Multiple Myeloma
            • POMALYST® (Pomalidomide)
            • Ansan, Korea, Republic of
            • +32 more
            Aug 17, 2022

            Juvenile Idiopathic Arthritis

            Not yet recruiting
            • Psoriatic Arthritis, Juvenile
            • Polyarticular Juvenile Idiopathic Arthritis
            • Seoul, Korea, Republic of
              Seoul National University Hospital
            Feb 22, 2023

            Atezolizumab in Ministry of Food and Drug Safety-Approved

            Completed
            • Urothelial Carcinoma
            • +4 more
            • Busan, Korea, Republic of
            • +55 more
            Aug 23, 2022

            Pneumococcal Disease Trial in Japan, Korea, Republic of, Taiwan (20vPnC, Saline, 13vPnC)

            Completed
            • Pneumococcal Disease
            • 20vPnC
            • +3 more
            • Itoshima, Fukuoka, Japan
            • +27 more
            Dec 5, 2022

            Antiphospholipid Syndrome, Ischemic Stroke, Transient Ischemic Attack Trial in Korea, Republic of (Antiplatelet Drug, Warfarin)

            Not yet recruiting
            • Antiphospholipid Syndrome
            • +5 more
            • Anyang, Korea, Republic of
            • +34 more
            Aug 15, 2023

            Progressive Supranuclear Palsy Trial in Seongnam-si, Seoul (GV1001 Placebo, GV1001 0.56mg, GV1001 1.12mg)

            Not yet recruiting
            • Progressive Supranuclear Palsy
            • GV1001 Placebo
            • +2 more
            • Seongnam-si, Korea, Republic of
            • +4 more
            Apr 19, 2023

            Essential Hypertension Trial in Korea, Republic of (Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg,

            Not yet recruiting
            • Essential Hypertension
            • Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg
            • Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mg
            • Seoul, Gyeonggi-do, Korea, Republic of
            • +11 more
            Sep 11, 2023

            Korea Osimertinib Real World Evidence Study to Assess Safety and

            Recruiting
            • Carcinoma, Non-Small-Cell Lung
              • Busan, Korea, Republic of
              • +10 more
              Aug 18, 2022

              Pneumococcal Disease Trial in Korea, Republic of (V114)

              Active, not recruiting
              • Pneumococcal Disease
              • V114
              • Jeonju-si, Jeonrabugdo, Korea, Republic of
              • +18 more
              Aug 17, 2022

              COVID-19, Vaccines Trial in Korea, Republic of (AdCLD-CoV19-1 OMI, Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran))

              Not yet recruiting
              • COVID-19
              • Vaccines
              • AdCLD-CoV19-1 OMI
              • Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran)
              • Busan, Korea, Republic of
              • +13 more
              Aug 15, 2023